Takeda

Three blocks displaying from left to right a person a handshake and another person
Biotech

BioCryst inks $700M Astria deal to rival Takeda in rare disease

The takeover will give the rare disease specialist control of a phase 3 challenger to Takeda’s hereditary angioedema therapy Takhzyro.
Nick Paul Taylor Oct 14, 2025 10:30am
Wood shavings and chisels on a workbench

Takeda turns to AI drug designer after whittling down R&D focus

Oct 14, 2025 5:00am
Red boxing gloves

Takeda lays off 137 US staff as part of cell therapy retreat

Oct 1, 2025 3:13pm
AI drug discovery pill machine learning drug targets data

BMS, Takeda join peers in push to improve AI by pooling data

Oct 1, 2025 10:34am
RNA Concept 3D Render

Japan biotech inks RNA research pact that includes mRNA compounds

Sep 19, 2025 10:49am
Alps parachute rainbow mountains

Takeda taps longtime Lilly exec as US head—Chutes & Ladders

Sep 12, 2025 8:30am